Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Heavy Cannabis Use, Dependence and the Brain: A Clinical Perspective.

Kroon E, Kuhns L, Hoch E, Cousijn J.

Addiction. 2019 Aug 13. doi: 10.1111/add.14776. [Epub ahead of print]

PMID:
31408248
2.

Cannabinoids and inflammation: Implications for People Living with HIV.

Costiniuk CT, Jenabian MA.

AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002345. [Epub ahead of print]

PMID:
31408029
3.

Developing a phone-based measure of impairment after acute oral ∆9-tetrahydrocannabinol.

Pabon E, de Wit H.

J Psychopharmacol. 2019 Aug 13:269881119862533. doi: 10.1177/0269881119862533. [Epub ahead of print]

PMID:
31407943
4.

Is there a relationship between cannabis use problems, emotion dysregulation, and mental health problems among adults with chronic pain?

Orr MF, Rogers AH, Shepherd JM, Buckner JD, Ditre JW, Bakhshaie J, Zvolensky MJ.

Psychol Health Med. 2019 Aug 13:1-14. doi: 10.1080/13548506.2019.1653485. [Epub ahead of print]

PMID:
31407604
5.

[Israeli Medical Cannabis Nursing Association (RA) first conference 18 Jan 2019 Sheba Medical Center].

Avishar I.

Harefuah. 2019 Aug;158(8):545-547. Hebrew. No abstract available.

PMID:
31407546
6.

Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?

Krämer M, Madea B, Hess C.

Drug Test Anal. 2019 Aug 12. doi: 10.1002/dta.2682. [Epub ahead of print]

PMID:
31407526
7.

Cannabis Use and Cognition in Adults Prescribed Opioids for Persistent Pain.

Wildes M, Bigand TL, Layton ME, Wilson M.

Pain Manag Nurs. 2019 Aug 9. pii: S1524-9042(19)30101-8. doi: 10.1016/j.pmn.2019.06.014. [Epub ahead of print]

PMID:
31405787
8.

Burden of Persistent Vomiting With Cannabis Use Disorder: Report From 55,549 Hospitalizations in the United States.

Patel RS, Patel J, Jaladi PR, Bhimanadham NN, Imran S, Tankersley WE.

Psychosomatics. 2019 Jul 11. pii: S0033-3182(19)30121-5. doi: 10.1016/j.psym.2019.07.003. [Epub ahead of print]

PMID:
31405569
9.

[Opioid maintenance treatment and Cannabis use].

Schneider U, Schäfer I, Hillemacher T, Cimander KF, Wedekind D, Weirich S, Havemann-Reinecke U.

Fortschr Neurol Psychiatr. 2019 Aug 12. doi: 10.1055/a-0918-5961. [Epub ahead of print] German.

PMID:
31404930
10.

Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada.

Fischer B, Jones W, Hall W, Kurdyak P.

Int J Drug Policy. 2019 Aug 9;73:96-99. doi: 10.1016/j.drugpo.2019.06.020. [Epub ahead of print] No abstract available.

PMID:
31404900
11.

Intertemporal decision-making-related brain states predict adolescent drug abuse intervention responses.

Elton A, Stanger C, James GA, Ryan-Pettes S, Budney A, Kilts CD.

Neuroimage Clin. 2019 Aug 5;24:101968. doi: 10.1016/j.nicl.2019.101968. [Epub ahead of print]

12.

Longitudinal Alterations in Prefrontal Resting Brain Connectivity in Non-Treatment-Seeking Young Adults With Cannabis Use Disorder.

Camchong J, Collins PF, Becker MP, Lim KO, Luciana M.

Front Psychiatry. 2019 Jul 25;10:514. doi: 10.3389/fpsyt.2019.00514. eCollection 2019.

13.

Back to the roots: protocol for the photoautotrophic micropropagation of medicinal Cannabis.

Kodym A, Leeb CJ.

Plant Cell Tissue Organ Cult. 2019;138(2):399-402. doi: 10.1007/s11240-019-01635-1. Epub 2019 Jun 5.

14.

Making a Case for Integrating Evidence-Based Sexual Risk Reduction and Mental Health Interventions for Adolescent Girls.

Morrison-Beedy D, Mazurek Melnyk B.

Issues Ment Health Nurs. 2019 Aug 12:1-10. doi: 10.1080/01612840.2019.1639087. [Epub ahead of print]

PMID:
31403363
15.

Differential Effects of Addictive Drugs on Sleep and Sleep Stages.

Gordon HW.

J Addict Res (OPAST Group). 2019;3(2). doi: 10.33140/JAR.03.02.01. Epub 2019 Jul 15.

PMID:
31403110
16.

Retention and Treatment Outcome of Youth with Cannabis Use Disorder Referred By the Legal System.

Kaminer Y, Ohannessian C, Burke R.

Adolesc Psychiatry (Hilversum). 2019 May;9(1):4-10. doi: 10.2174/2210676608666181102145040.

17.

Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome.

Parvataneni S, Varela L, Vemuri-Reddy SM, Maneval ML.

Cureus. 2019 Jun 4;11(6):e4825. doi: 10.7759/cureus.4825.

18.

Phenotypic Variation of Cell Wall Composition and Stem Morphology in Hemp (Cannabis sativa L.): Optimization of Methods.

Petit J, Gulisano A, Dechesne A, Trindade LM.

Front Plant Sci. 2019 Jul 25;10:959. doi: 10.3389/fpls.2019.00959. eCollection 2019.

19.

Urgent need for "EBMM" in pediatric oncology: Evidence based medical marijuana.

Rod Rassekh S.

Pediatr Hematol Oncol. 2019 Aug 12:1-2. doi: 10.1080/08880018.2019.1651805. [Epub ahead of print]

PMID:
31402734
20.

Pharmacologic chaos: severe hypotension from interactions of anesthetics, marijuana, amphetamines, and paroxetine.

Cossu AE, Latham LB, Hardacker DM, Jea AH.

J Clin Anesth. 2019 Aug;55:17. doi: 10.1016/j.jclinane.2018.12.040. Epub 2018 Dec 24. No abstract available.

PMID:
30586660

Supplemental Content

Loading ...
Support Center